logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Tobias Mielke

johnson & johnson

6H-index
33Paper Count
150Citation Count
Published Papers 8
Publication Date
logo
Design, simulate, refine: simulation-guided clinical trials for accelerated drug development
errNature Reviews Drug Discovery
IF101.8
err2026-07-13
err0
PREAI
errElias Laurin Meyer; Tim Friede; Andrew P. Grieve; Christopher Jennison; Michael Krams; Elizabeth Lorenzi; Husseini K. Manji; Tobias Mielke; Jessica R. Overbey; Kert Viele; Marc K. Walton; Franz König
errShare
errSave
Rejoinder - Statistical Methodology Groups in the Pharmaceutical Industry#
errStatistics in Biopharmaceutical Research
IF1.3
err2026-04-30
err0
PREAI
errDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
errShare
errSave
Statistical Methodology Groups in the Pharmaceutical Industry#
errStatistics in Biopharmaceutical Research
IF1.3
err2026-04-09
err1
PREAI
errDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
errShare
errSave
Correction: Randomization in the age of platform trials: unexplored challenges and some potential solutions
errBMC Medical Research Methodology
IF3.4
err2026-02-05
err0
errOAAI
errOlga Kuznetsova; Jennifer Ross; Daniel Bodden; Freda Cooner; Jonathan Chipman; Peter Jacko; Johannes Krisam; Yuqun Abigail Luo; Tobias Mielke; David S. Robertson; Yevgen Ryeznik; Sofia S. Villar; Wenle Zhao; Oleksandr Sverdlov
errShare
errSave
Phase 2 Design Considerations from a Program Perspective
errStatistics in Biopharmaceutical Research
IF1.3
err2026-02-01
err0
PREAI
errMielke, Tobias; Ohrn, Fredrik; Dragalin, Vladimir
errShare
errSave
Randomization in the age of platform trials: unexplored challenges and some potential solutions
errBMC Medical Research Methodology
IF3.4
err2025-11-23
err0
errOAAI
errOlga Kuznetsova; Jennifer Ross; Daniel Bodden; Freda Cooner; Jonathan Chipman; Peter Jacko; Johannes Krisam; Yuqun Abigail Luo; Tobias Mielke; David S. Robertson; Yevgen Ryeznik; Sofia S. Villar; Wenle Zhao; Oleksandr Sverdlov
errShare
errSave
Why and how should we simulate platform trials? Learnings from EU-PEARL
errBMC MEDICAL RESEARCH METHODOLOGY
IF3.4
err2025-01-17
err1
errOAAI
errMeyer, Elias Laurin; Mielke, Tobias; Roig, Marta Bofill; Freitag, Michaela Maria; Jacko, Peter; Krotka, Pavla; Mesenbrink, Peter; Parke, Tom; Zehetmayer, Sonja; Zocholl, Dario; Koenig, Franz
errShare
errSave
Regulatory Issues of Platform Trials: Learnings from EU-PEARL
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2024-03-26
err3
errOAAI
errNguyen, Quynh Lan; Hees, Katharina; Penna, Sabina Hernandez; Koenig, Franz; Posch, Martin; Roig, Marta Bofill; Meyer, Elias Laurin; Freitag, Michaela Maria; Parke, Tom; Otte, Maximilian; Dauben, Hans-Peter; Mielke, Tobias; Spiertz, Cecile; Mesenbrink, Peter; Gidh-Jain, Madhavi; Pierre, Suzanne; Morello, Salvatore; Hofner, Benjamin
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
H
Husseini K. Manji
H-index: 101 · Papers: 881
T
Tim Friede
H-index: 65 · Papers: 633
M
Martin Posch
H-index: 53 · Papers: 340
P
Philip Hougaard
H-index: 53 · Papers: 159
K
Kaspar Rufibach
H-index: 44 · Papers: 182
View more